Target N. V. Biotech Sells 1,279,820 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) Stock November 19, 2024 by InsiderTrades.com Share Molecular Templates, Inc. (NASDAQ:MTEM - Get Free Report) major shareholder Target N. V. Biotech sold 1,279,820 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $0.66, for a total value of $844,681.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.Molecular Templates Price PerformanceShares of NASDAQ MTEM opened at $0.45 on Tuesday. The stock has a market capitalization of $2.98 million, a PE ratio of -0.17 and a beta of 1.22. Molecular Templates, Inc. has a one year low of $0.30 and a one year high of $5.37. The business's fifty day moving average price is $0.91 and its 200-day moving average price is $1.21. About Molecular Templates (Get Free Report)Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).Recommended StoriesFive stocks we like better than Molecular TemplatesDividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Applied Materials Market Capitulates: Now is the Time to BuyHow to Find Undervalued Stocks3 Ultra-High Dividend Yield Stocks for the New YearThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Molecular Templates? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Molecular Templates and related companies. More From MarketBeatThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThe 7 Best Electric Vehicle Stocks That Aren't TeslaWe all know that electric vehicles are the future of day-to-day transportation. They are simpler to manufactur...MarketBeatMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored7 Chip Stocks to Buy on the DipFor much of the industrial era, semiconductors (i.e. chips) were a cyclical sector. For investors, that meant ...MarketBeatMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe Best Energy Stocks to Buy NowWith recent disruptions in the international energy markets, there has been a renewed attention on public ener...MarketBeat24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Most Read This MonthInsider Buying Signals Upside for These 3 StocksChristopher Huskilson Buys 25,000 Shares of Algonquin Power & Utilities Corp. (TSE:AQN) StockInsider Selling: SoFi Technologies, Inc. (NASDAQ:SOFI) EVP Sells $96,430.88 in StockInsiders Bet Big on These Small Cap StocksLucid Group, Inc. (NASDAQ:LCID) Director Public Investment Fund Buys 374,717,927 SharesAlphabet Inc. (NASDAQ:GOOGL) Director Sells $1,862,805.00 in StockTG Therapeutics, Inc. (NASDAQ:TGTX) Director Sells $152,200.00 in StockInsiders Are Buying High-Yielding Delek Logistics PartnersRecent ArticlesBonilla Luis Miguel Palomino Sells 101 Shares of Southern Copper Co. (NYSE:SCCO) StockInsider Selling: JFrog Ltd. (NASDAQ:FROG) CFO Sells 347 Shares of StockThomas K. Equels Acquires 60,110 Shares of AIM ImmunoTech Inc. (NYSE:AIM) StockAtara Biotherapeutics, Inc. (NASDAQ:ATRA) EVP Sells $11,200.00 in StockFrederick D. Disanto Buys 407 Shares of The Eastern Company (NASDAQ:EML) StockMarcela V. Maus Sells 3,900 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) StockJulia Brncic Sells 740 Shares of EverQuote, Inc. (NASDAQ:EVER) StockUpwork Inc. (NASDAQ:UPWK) CAO Sells $14,797.14 in Stock
